<SEC-DOCUMENT>0000950170-24-106167-index.html : 20240912
<SEC-HEADER>0000950170-24-106167.hdr.sgml : 20240912
<ACCEPTANCE-DATETIME>20240912212454
ACCESSION NUMBER:		0000950170-24-106167
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20240912
FILED AS OF DATE:		20240912
DATE AS OF CHANGE:		20240912

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Simson Jake
		CENTRAL INDEX KEY:			0001863094
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42271
		FILM NUMBER:		241296290

	MAIL ADDRESS:	
		STREET 1:		C/O JANUX THERAPEUTICS, INC.
		STREET 2:		11099 N. TORREY PINES ROAD, SUITE 290
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bicara Therapeutics Inc.
		CENTRAL INDEX KEY:			0002023658
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		245 MAIN STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-785-8308

	MAIL ADDRESS:	
		STREET 1:		245 MAIN STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>3
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ck0002023658-ex24.htm
<DESCRIPTION>EX-24
<TEXT>
Document 2 - file: ck0002023658-ex24.htm

</DOCUMENT>
</SEC-DOCUMENT>